FOLD Operating Cash Flow (Statement)
Amicus Therapeutics Inc · Operating Cash Flow (Statement)
FOLD Operating Cash Flow (Statement)
Latest reported$16.25Mperiod ending
FOLD Quarterly Cash from Operations (-$10.74M → $16.25M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
FOLD operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 16,253,000 | |
| 35,660,000 | |
| -26,526,000 | |
| 7,758,000 | |
| -3,916,000 | |
| -22,971,000 | |
| 22,691,000 | |
| -29,695,000 | |
| 3,458,000 | |
| -38,347,000 | |
| -16,133,000 | |
| -18,069,000 | |
| -80,772,000 | |
| -11,626,000 | |
| -15,862,000 | |
| -58,315,000 | |
| -70,514,000 | |
| -23,700,000 | |
| -35,923,000 | |
| -72,354,000 | |
| -49,822,000 | |
| -42,008,000 | |
| -33,518,000 | |
| -107,942,000 | |
| -57,832,000 | |
| -55,553,000 | |
| -58,485,000 | |
| -78,546,000 | |
| -60,677,000 | |
| -132,762,000 | |
| -56,995,000 | |
| -49,521,000 | |
| -73,767,000 | |
| -49,955,000 | |
| -41,919,000 | |
| -49,844,000 | |
| -31,985,000 | |
| -40,878,000 | |
| -32,735,000 | |
| -44,936,000 | |
| -35,511,000 | |
| -21,017,000 | |
| -22,636,000 | |
| -20,975,000 | |
| -14,508,000 | |
| -15,122,000 | |
| -11,819,000 | |
| -10,220,000 | |
| -8,120,000 | |
| -13,513,000 | |
| -10,261,000 | |
| -13,900,000 | |
| -7,374,000 | |
| -7,200,000 | |
| -11,131,000 | |
| -8,039,000 | |
| -12,521,000 | |
| -12,988,000 | |
| -10,607,000 | |
| -13,306,000 | |
| 22,365,000 | |
| -11,063,000 | |
| -11,856,000 | |
| -13,429,000 | |
| -10,592,000 | |
| -11,474,000 | |
| -10,455,000 | |
| -10,850,000 | |
| -14,298,000 | |
| -7,625,000 | |
| -7,744,000 | |
| -7,196,000 | |
| 42,412,000 | |
| -6,104,000 | |
| -10,380,000 | |
| -10,736,000 |